Approval · Notice of Compliance 34161 · 2024
MESALAMINE: Notice of Compliance 34161
Issued October 8, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34161
- Date
- October 8, 2024
- Company
- Tillotts Pharma GmbhRheinfelden, Baden-Wuerttemberg, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Addition of product name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MESALAMINE | 02552426 | Approved |
Medicinal ingredients
- MESALAZINE 800 MG per TAB